AUG 14, 2026 · JOURNAL ARTICLE
A Gelatin‐Oxidized Dextran Hydrogel for Co‐Delivery of γδT Cells and Immunostimulatory Agents Potentiates Local Cancer Immunotherapy
Small
This is an early-stage preclinical study in a xenograft model demonstrating proof-of-concept for a novel hydrogel delivery system, lacking human clinical data and reporting only surrogate tumor outcomes without survival numbers.
Study details
DesignPreclinical in vivo xenograft study
InterventionInjectable hydrogel (oxidized dextran-gelat…